Once-monthly oral ibandronate provides significant improvement in bone mineral density in postmenopausal women treated with glucocorticoids for inflammatory rheumatic diseases: a 12-month, randomized, double-blind, placebo-controlled trial

Hakala, Markku; Kröger, Heikki; Valleala, Heikki; Hienonen-Kempas, Tuija; Lehtonen-Veromaa, Marjo; Heikkinen, Jorma; Tuomiranta, Tapani; Hannonen, Pekka; Paimela, Leena; the ONCE trial group, for

doi:10.3109/03009742.2012.664647

Public

Once-monthly oral ibandronate provides significant improvement in bone mineral density in postmenopausal women treated with glucocorticoids for inflammatory rheumatic diseases: a 12-month, randomized, double-blind, placebo-controlled trial

Published in Scandinavian Journal of Rheumatology • Jul 18, 2012

Authors:

Markku Hakala

Heikki Kröger

Heikki Valleala

Abstract

OBJECTIVES: To study the efficacy and safety of once-monthly oral ibandronate in the prevention of glucocorticoid (GC)-induced osteoporosis (GIOP) in postmenopausal women with inflammatory rheumatic diseases. METHOD: A randomized, double-blind, placebo-controlled, parallel-group study of 140 postmen...

Subject

Medicine

Bone mineral

Randomized controlled trial

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!